Vora, A., Dai, D. D., Matsouaka, R., Harrison, J. K., Hughes, G. C., Sherwood, M., … Vemulapalli, S. (2017). NEW-ONSET ATRIAL FIBRILLATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: INCIDENCE, ANTICOAGULANT STRATEGY, AND OUTCOMES. In Journal of the American College of Cardiology (Vol. 69, pp. 961–961). Elsevier BV. https://doi.org/10.1016/s0735-1097(17)34350-4

Vora, Amit, Dadi David Dai, Roland Matsouaka, J Kevin Harrison, G Chad Hughes, Matthew Sherwood, Jonathan Piccini, et al. “NEW-ONSET ATRIAL FIBRILLATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: INCIDENCE, ANTICOAGULANT STRATEGY, AND OUTCOMES.” In Journal of the American College of Cardiology, 69:961–961. Elsevier BV, 2017. https://doi.org/10.1016/s0735-1097(17)34350-4.

Vora A, Dai DD, Matsouaka R, Harrison JK, Hughes GC, Sherwood M, et al. NEW-ONSET ATRIAL FIBRILLATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: INCIDENCE, ANTICOAGULANT STRATEGY, AND OUTCOMES. In: Journal of the American College of Cardiology. Elsevier BV; 2017. p. 961–961.

Vora, Amit, et al. “NEW-ONSET ATRIAL FIBRILLATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: INCIDENCE, ANTICOAGULANT STRATEGY, AND OUTCOMES.” Journal of the American College of Cardiology, vol. 69, no. 11, Elsevier BV, 2017, pp. 961–961. Crossref, doi:10.1016/s0735-1097(17)34350-4.

Vora A, Dai DD, Matsouaka R, Harrison JK, Hughes GC, Sherwood M, Piccini J, Cohen D, Holmes D, Bhardwaj B, Thourani V, Peterson E, Vemulapalli S. NEW-ONSET ATRIAL FIBRILLATION FOLLOWING TRANSCATHETER AORTIC VALVE REPLACEMENT: INCIDENCE, ANTICOAGULANT STRATEGY, AND OUTCOMES. Journal of the American College of Cardiology. Elsevier BV; 2017. p. 961–961.